CRDN Celebrates Continued Federal Investment in the National Strategy for Drugs for Rare Diseases
CRDN celebrates continued federal funding for Canada’s rare disease drug strategy and highlights the importance of connecting treatment access with timely diagnosis, coordinated care, and research.